Evidence map›Paper›PMID 41889583›Full record

ArticleFrontiers in toxicology2026

Berry e-liquid flavour toxicities are not equal on an alveolar-capillary barrier cell model according to two exposure methods.

Emma Filaudeau, Amelia-Naomi Sabo, Anita Lebert, Laurent Monassier, Véronique Kemmel

Abstract read
In one paragraph

Article in Frontiers in toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Emma FilaudeauLaboratoire de Pharmacologie et Toxicologie Neurocardiovasculaire, UR 7296, Centre de Recherche en Biomédecine de Strasbourg (CRBS), Faculté de Médecine, Maïeutique et Sciences de la Santé, Strasbourg, France.
Amelia-Naomi SaboLaboratoire de Pharmacologie et Toxicologie Neurocardiovasculaire, UR 7296, Centre de Recherche en Biomédecine de Strasbourg (CRBS), Faculté de Médecine, Maïeutique et Sciences de la Santé, Strasbourg, France.
Anita LebertLaboratoire de Pharmacologie et Toxicologie Neurocardiovasculaire, UR 7296, Centre de Recherche en Biomédecine de Strasbourg (CRBS), Faculté de Médecine, Maïeutique et Sciences de la Santé, Strasbourg, France.
Laurent MonassierLaboratoire de Pharmacologie et Toxicologie Neurocardiovasculaire, UR 7296, Centre de Recherche en Biomédecine de Strasbourg (CRBS), Faculté de Médecine, Maïeutique et Sciences de la Santé, Strasbourg, France.
Véronique KemmelLaboratoire de Pharmacologie et Toxicologie Neurocardiovasculaire, UR 7296, Centre de Recherche en Biomédecine de Strasbourg (CRBS), Faculté de Médecine, Maïeutique et Sciences de la Santé, Strasbourg, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

E-cigarettes are often presented as a smoking cessation tool, less harmful than tobacco and are now a regular feature of everyday life. However, the fruity and sweet flavours are attractive to teenagers who can use them recreationnaly. The main risk of this phenomenon is becoming trapped in nicotine addiction. Although e-liquids, which combine nicotine, humectants and flavouring agents, seem to affect the pulmonary system and in particular the alveolar-capillary barrier (ACB), data on nicotine-free e-liquids remain scarce. The aim of this work is to study the toxicity of nicotine-free e-liquids/aerosols flavoured with berries (Strawberry, Raspberry, Blackberry, Blueberry) using two exposure methods. First, we validated an

Indexed as

alveolar-capillary barrierbarrier integrityberry flavourse-cigaretteoxidative stresstrapped aerosol

Identifiers

PMID41889583
PMCPMC13012864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.